Genetic counseling for prion disease: Updates and best practices
- PMID: 35819418
- DOI: 10.1016/j.gim.2022.06.003
Genetic counseling for prion disease: Updates and best practices
Abstract
Prion disease is a rare, fatal, and often rapidly progressive neurodegenerative disease. Ten to fifteen percent of cases are caused by autosomal dominant gain-of-function variants in the prion protein gene, PRNP. Rarity and phenotypic variability complicate diagnosis, often obscuring family history and leaving families unprepared for the genetic implications of an index case. Several recent developments inspire this update in best practices for prion disease genetic counseling. A new prion-detection assay has transformed symptomatic diagnosis. Meanwhile, penetrance, age of onset, and duration of illness have been systematically characterized across PRNP variants in a global cohort. Clinically, the traditional genotype-phenotype correlation has weakened over time, and the term genetic prion disease may now better serve providers than the historical subtypes Creutzfeldt-Jakob disease, fatal familial insomnia, and Gerstmann-Sträussler-Scheinker disease. Finally, in the age of genetically targeted therapies, clinical trials for prion disease are being envisaged, and healthy at-risk individuals may be best positioned to benefit. Such individuals need to be able to access clinical services for genetic counseling and testing. Thus, this update on the genetics of prion disease and best practices for genetic counseling for this disease aims to provide the information needed to expand genetic counseling services.
Keywords: Creutzfeldt-Jakob disease (CJD); Fatal familial insomnia (FFI); Gerstmann-Sträussler-Scheinker disease (GSS); PRNP; Prion disease.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest SMV has received speaking fees from Ultragenyx, Illumina, and Biogen, consulting fees from Invitae, and research support in the form of unrestricted charitable contributions from Ionis Pharmaceuticals.
Similar articles
-
Prion Mutations in Republic of Republic of Korea, China, and Japan.Int J Mol Sci. 2022 Dec 30;24(1):625. doi: 10.3390/ijms24010625. Int J Mol Sci. 2022. PMID: 36614069 Free PMC article. Review.
-
Genetic Prion Disease: Insight from the Features and Experience of China National Surveillance for Creutzfeldt-Jakob Disease.Neurosci Bull. 2021 Nov;37(11):1570-1582. doi: 10.1007/s12264-021-00764-y. Epub 2021 Sep 6. Neurosci Bull. 2021. PMID: 34487324 Free PMC article.
-
[Genetic background of human prion diseases].Ideggyogy Sz. 2007 Nov 30;60(11-12):438-46. Ideggyogy Sz. 2007. PMID: 18198790 Review. Hungarian.
-
The prion diseases.J Geriatr Psychiatry Neurol. 2010 Dec;23(4):277-98. doi: 10.1177/0891988710383576. Epub 2010 Oct 11. J Geriatr Psychiatry Neurol. 2010. PMID: 20938044 Review.
-
Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.Brain. 2022 Apr 18;145(2):700-712. doi: 10.1093/brain/awab350. Brain. 2022. PMID: 35288744 Free PMC article.
Cited by
-
The First Genetic Characterization of the SPRN Gene in Pekin Ducks (Anas platyrhynchos domesticus).Animals (Basel). 2024 May 27;14(11):1588. doi: 10.3390/ani14111588. Animals (Basel). 2024. PMID: 38891635 Free PMC article.
-
Understanding the key features of the spontaneous formation of bona fide prions through a novel methodology that enables their swift and consistent generation.Acta Neuropathol Commun. 2023 Sep 7;11(1):145. doi: 10.1186/s40478-023-01640-8. Acta Neuropathol Commun. 2023. PMID: 37679832 Free PMC article.
-
Therapeutic Trial of anle138b in Mouse Models of Genetic Prion Disease.J Virol. 2023 Feb 28;97(2):e0167222. doi: 10.1128/jvi.01672-22. Epub 2023 Jan 18. J Virol. 2023. PMID: 36651748 Free PMC article.
-
Human prion diseases and the prion protein - what is the current state of knowledge?Transl Neurosci. 2023 Oct 16;14(1):20220315. doi: 10.1515/tnsci-2022-0315. eCollection 2023 Jan 1. Transl Neurosci. 2023. PMID: 37854584 Free PMC article. Review.
-
NGS study in a sicilian case series with a genetic diagnosis for Gerstmann-Sträussler-Scheinker syndrome (PRNP, p.P102L).Mol Biol Rep. 2023 Nov;50(11):9715-9720. doi: 10.1007/s11033-023-08764-z. Epub 2023 Oct 9. Mol Biol Rep. 2023. PMID: 37812352
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous